First-trimester neutrophil percentage-to-albumin ratio: a novel predictor for preeclampsia
Authors:
- 25 May 2025
- journal article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 19 (11) , 415-423
Abstract
This retrospective study evaluated the predictive power of a new marker for pre-eclampsia (PE), the neutrophil percentage/albumin ratio (NPAR). A total of 399 participants consisting of 133 pregnant women diagnosed with PE and 266 healthy pregnant controls were included in the study. Data collected included demographic and obstetric history, gestational age at diagnosis, maternal hematological and biochemical parameters, first trimester neutrophil/albumin ratio (NAR) and NPAR values, and neonatal outcomes. The pre-eclampsia group showed significantly higher NAR (mean: 312.30, range: 80.00-1568.00) and NPAR (mean: 3.14 ± 0.81) compared to the control group (mean NAR: 234.40, range: 78.16-725.00; mean NPAR: 2.06 ± 0.38; p = 0.001 for both). Furthermore, early-onset PE was associated with significantly higher NAR (395.00 vs. 256.23, p = 0.001) and NPAR (3.87 vs. 2.80, p = 0.001) compared to late-onset PE. For early-onset PE, NPAR showed a sensitivity of 76.19%, specificity of 92.31%, PPV of 82.05%, NPV of 89.36% and area under the curve (AUC) of 0.897, demonstrating its strong potential as an early predictor of pre-eclampsia. NPAR is elevated in PE compared to healthy pregnancies, demonstrating its potential as a simple yet effective biomarker for predicting PE.Keywords
This publication has 42 references indexed in Scilit:
- The role of first trimester eosinophil count and eosinophil-based complete blood cell indices in the predictiction of preeclampsia: A case-control studyPlacenta, 2023
- Syncytin-1 nonfusogenic activities modulate inflammation and contribute to preeclampsia pathogenesisCellular and Molecular Life Sciences, 2022
- Clinical tools and biomarkers to predict preeclampsiaEBioMedicine, 2021
- The Role of Neutrophils and Their Extracellular Traps in the Synergy of Pre-eclampsia and HIV InfectionCurrent Hypertension Reports, 2020
- Screening for pre‐eclampsia at 11–13 weeks' gestation: use of pregnancy‐associated plasma protein‐A, placental growth factor or bothUltrasound in Obstetrics & Gynecology, 2020
- Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: A meta-analysis including 3982 patientsPregnancy Hypertension, 2020
- Association between first trimester plasma htra1 level and subsequent preeclampsia: A possible early marker?Pregnancy Hypertension, 2019
- Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) StudyAtherosclerosis, 2012
- The Two Stage Model of Preeclampsia: Variations on the ThemePlacenta, 2009
- The antioxidant properties of serum albuminFEBS Letters, 2008